Status:
COMPLETED
Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk Factors
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Polymorphism, Restriction Fragment Length
Eligibility:
All Genders
Brief Summary
The aim of the study is to determine the relationship between VEGF gene expression, VEGF gene polymorphism and serum leptin concentration in the Polish population in people with excessive body weight....
Detailed Description
400 people (250 - study group; 150 control group) were subjected to subjective and objective action. Information on the occurrence of diseases and cardiovascular risk in the participant and his family...
Eligibility Criteria
Inclusion
- informed consent in writing
- stable body mass (+/- 1 kg)
- excessive body mass (BMI ≥ 25 kg/m2- study group)
- proper body mass (BMI \< 25 kg/m2- control group)
Exclusion
- age \<18 years
- secondary obesity
- pregnancy, lactation
- other conditions that in the opinion of researchers may pose any risk to the patient during the study.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04077554
Start Date
January 1 2018
End Date
August 30 2019
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences
Poznan, Wielkopolska, Poland, 60-569